drugset / Trial / NCT01486914

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process

NCT01486914

Phase 1 Completed 28 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare insulin aspart produced by current process and the NN2000 process.

Timeline

Start
2003-01-19
Primary completion
2003-02-24
Completion
2003-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic Subcutaneous

Indications